| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
major histocompatibility complex, class II, DQ beta 1 | 0.407 | 0.885 | 8.9E-03 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
C-C motif chemokine receptor 2 | 0.418 | 0.846 | 2.3E-02 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2003 | 2003 | ||||||||
|
kinase insert domain receptor | 0.378 | 0.885 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 1 | 0.537 | 0.769 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | |||||||||
|
killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 2 | 0.543 | 0.769 | 6.1E-12 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
actin gamma 2, smooth muscle | 0.505 | 0.808 | 7.1E-02 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1998 | 1998 | ||||||||
|
low density lipoprotein receptor | 0.449 | 0.885 | 9.8E-24 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
galectin 3 | 0.392 | 0.846 | 2.3E-05 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
DNA topoisomerase II alpha | 0.497 | 0.731 | 0.99 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
actin gamma 1 | 0.477 | 0.846 | 4.8E-03 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1998 | 1998 | ||||||||
|
lymphotoxin beta | 0.555 | 0.769 | 9.6E-11 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
class II major histocompatibility complex transactivator | 0.536 | 0.808 | 1.4E-07 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
MHC class I polypeptide-related sequence B | 0.576 | 0.731 | 4.1E-05 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2006 | 2006 | ||||||||
|
MNAT1 component of CDK activating kinase | 0.539 | 0.846 | 1.3E-12 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1996 | 1996 | ||||||||
|
interleukin 15 | 0.422 | 0.846 | 0.71 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1999 | 1999 | ||||||||
|
interleukin 13 receptor subunit alpha 1 | 0.659 | 0.577 | 0.96 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
interleukin 13 | 0.386 | 0.846 | 1.4E-02 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
major histocompatibility complex, class II, DR beta 4 | 0.565 | 0.846 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 | |||||||||
|
heat shock protein family E (Hsp10) member 1 | 0.617 | 0.769 | 0.80 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
apolipoprotein A1 | 0.429 | 0.885 | 5.5E-04 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
stimulator of interferon response cGAMP interactor 1 | 0.522 | 0.769 | 1.2E-03 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
immunity related GTPase M | 0.617 | 0.538 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | |||||||||
|
actin beta like 2 | 0.539 | 0.769 | 5.8E-16 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1998 | 1998 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
insulin like growth factor 1 | 0.318 | 0.885 | 0.27 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 |